Facilitated By

San Antonio Medical Foundation

A Collaboration of the San Antonio Bioscience and Medical Research Community

A first-of-its-kind initiative between public and private sector to catalog and highlight Bioscience research in the city of San Antonio and the surrounding areas.

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations

HARNESSING THE POWER OF CTSA-CDRN DATA NETWORKS: USING SOCIAL DETERMINANTS OF HEALTH, FRAILTY AND FUNCTIONAL STATUS TO IDENTIFY AT-RISK PATIENTS AND IMPROVE RISK ADJUSTMENT

Postoperative complications and readmissions rates are higher in minority and low socioeconomic status (SES)patients. Low SES is associated with frailty, one of the best predictors of 30-day postoperative complicationsand early hospital readmission. Despite their influence on health outcomes, frailty and social risk factors are notconsidered in risk adjustment for reimbursement and quality measures. CMS developed financial incentive-based programs to improve quality of care.

UT Health San Antonio
Shireman, Paula Kay
More Info
A Master Protocol Of Phase 1/2 Studies Of Nivolumab In Advanced Nsclc Using Nivolumab As Maintenance After Induction Chemotherapy Or As First-Line Treatment Alone Or In Combination With Standard Of Care Therapies

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide, accounting for approximately 18% of all cancer deaths.1 Despite treatment with platinum-based chemotherapy, the standard of care for first-line therapy, patients with metastatic NSCLC have a median survival of approximately 10 months, and a 5-year survival rate of less than 5%. Immunotherapeutic approaches have demonstrated clinical efficacy in several cancer types, including melanoma, hormone-refractory prostate cancer, and lung cancer.3,4.

Brooke Army Medical Center
Email for information
More Info